As a possible mechanism of chemotherapy resistance in CRC, the authors proposed that shed SDC1 may interact with soluble heparin-binding EGF-like growth factor enhancing the activation of EGFR and downstream signaling, which in turn decreases the chemotherapeutical sensitivity of colon cancer cells (38). The gene discussed is HBEGF; the disease is malignant colon neoplasm.